Literature DB >> 8164870

Ethical concerns for physicians deployed to Operation Desert Storm.

B S Carter1.   

Abstract

A survey of 600 Army and Navy physicians deployed to the Persian Gulf during Operation Desert Storm was conducted to ascertain their concerns pertaining to the ethics of combat medicine and note any similarities with common ethical concerns in the peacetime practice of medicine. Despite expressed familiarity with the Geneva Convention of 1949 outlining care of enemy wounded and civilian populations, many stated that these guidelines did not apply to their practice experience. Thirty-three percent disagreed with medical need as the sole determinant for care in triage, and 22% stated that enemy prisoners of war should receive care only after allied forces had been treated. Other concerns about the ethical practice of medicine during and after war were raised to include access to care, balancing goods and harms, resource allocation, and the definition of medical futility.

Keywords:  Bioethics and Professional Ethics; Empirical Approach; War and Human Rights Abuses

Mesh:

Year:  1994        PMID: 8164870

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

1.  Comradery, community, and care in military medical ethics.

Authors:  Michael L Gross
Journal:  Theor Med Bioeth       Date:  2011-10

2.  Fresh whole blood transfusions in coalition military, foreign national, and enemy combatant patients during Operation Iraqi Freedom at a U.S. combat support hospital.

Authors:  Philip C Spinella; Jeremy G Perkins; Kurt W Grathwohl; Thomas Repine; Alec C Beekley; James Sebesta; Donald Jenkins; Kenneth Azarow; John B Holcomb
Journal:  World J Surg       Date:  2007-11-09       Impact factor: 3.352

3.  Ethical challenges faced by French military doctors deployed in the Sahel (Operation Barkhane): a qualitative study.

Authors:  Antoine Lamblin; Clément Derkenne; Marion Trousselard; Marie-Ange Einaudi
Journal:  BMC Med Ethics       Date:  2021-11-19       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.